Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study)Juergen Rech,Arnd Kleyer,Mikkel Ostergaard,Melanie Hagen,Larissa Valor Mendez,Koray Tascilar,Gerhard Kroenke,Verena Schoenau,David Simon,Stefan Kleinert,Xenofon Baraliakos,Juergen Braun,Axel Hueber,Martin Fleck,Andrea Rubbert-Roth,Frank Behrens, Martin Feuchtenberger, M. Zaenker,Reinhard Voll, Cornelia Glaser,Maria Filkova,Eugen Feist,Gerd Burmester, Kirsten Karberg,Johannes Strunk, Juan Canete,Ladislav Senolt,Esperanza Naredo, Georg SchettARTHRITIS & RHEUMATOLOGY（2022）引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
